ライフサイエンスコーパス: P value

1 zed by the mean of ranks and a corresponding P value.

2 or replacing traditional approaches based on P values.

3 imal to truncate variants according to their P-values.

4 s" (ADA) method removes variants with larger P-values.

5 -Whitney test and Bonferroni's adjustment of p-values.

6 tational cost required to rigorously compute P -values.

7 hydrophobicities as inferred from their log(P) values.

8 tion process at E(p) = 1.20 V with various t(p) values.

9 tio [HR] 0.712, 96% CI 0.56-0.906; one-sided p value 0.0018).

10 oup, HR 0.709, 95% CI 0.524-0.959; two-sided p value 0.025).

11 re wrinkle on upper lip per increase of IQR, P-value 0.0218).

12 ehead (12.5% more spots per increase of IQR, P-value 0.0371), and wrinkle on upper lip (7.7% more wri

13 rogression-free survival (PFS) (Kaplan-Meier P value = 0.0166) between patients designated as chemore

14 families have marginally greater similarity (P value = 0.02) to unrelated affected individuals.

15 h a viral load below 800 000 (100% vs 83.9%, P value = 0.022).

16 for 30-, 60-, and 90-day surgical mortality (P values = 0.97, 0.65, and 0.46, respectively).

17 s found for the 5-HTTLPR/rs25531 S A allele (p-value = 0.0046)- which directs reduced expression of t

18 suicidal risk before Bonferroni correction (p-value = 0.0174).

19 p testing and regression, Porphyromonas (FDR p-value = 0.02), Prevotella (FDR p-value = 0.03), Anaero

20 omonas (FDR p-value = 0.02), Prevotella (FDR p-value = 0.03), Anaerococcus (FDR p-value = 0.07), and

21 atrine coverage was associated with a 0.031 (p-value = 0.040) increase in height-for-age z-score.

22 (rs201622589, MAF 0.1%, odds ratio = 10.13, p-value = 0.042) and results in complete loss of secreti

23 ella (FDR p-value = 0.03), Anaerococcus (FDR p-value = 0.07), and Dialister (FDR p-value = 0.09) were

24 cus (FDR p-value = 0.07), and Dialister (FDR p-value = 0.09) were detected at higher relative abundan

25 10(-16)), but not with more pigmented spots (P-value = 0.30).

26 orical data (3.3% versus 6.3%, respectively; P value =0.0008).

27 o, 0.63; 95% confidence interval, 0.46-0.85; P value =0.003).

28 vely; chi21 = 20.26; P < .001; difference in P values, 0.48; 95% CI, 0.29-0.68).

29 groups was 3.28 (95% CI 1.67-6.44; adjusted p value=0.0002).

30 groups (HR 0.48, 95% CI 0.23-0.99; log-rank p value=0.0434).

31 tical evidence of heterogeneity (interaction P value=0.18) between the primary (HR, 0.98; 95% CI, 0.7

32 sus HR, 1.52; 95% CI, 0.70-3.29; interaction P value=0.63).

33 sus HR, 0.63; 95% CI, 0.39-1.02; interaction P value=0.73) and heart failure hospitalization (HR, 0.6

34 sus HR, 0.64; 95% CI, 0.35-1.15; interaction P value=0.91) were similarly reduced in the secondary an

35 37; 95% confidence interval (CI), 1.09-1.67; P-value=0.007).

36 al life events (0.12% of variance explained, P-value=0.0076) contributing positively to the risk of d

37 l values (before digestion) in potato chips (p-value=0.027).

38 tion was found (n=130 lupic patient samples, p-value=0.0413).

39 crylamide values were statistically similar (p-value=0.132) for French fries and lower than the initi

40 0.43-0.61) decreasing their risk of AD more (P value = .01) than men (OR, 0.71; 95% CI, 0.60-0.85).

41 smallest annulus had the best AUROC values (P values: .0317 to .0380).

42 %) in the placebo arm (risk difference, 3.1; P value .04).

43 ckness AUROC values for all 4 annulus sizes (P values: .0593 to .6866).

44 natural log-transformed 25OHD per A allele; p value = 1.5 x 10(-88)).

45 various functions such as brain development (P-value = 1.12E-2), nervous system development (P-value

46 alue = 1.12E-2), nervous system development (P-value = 1.26E-3), and cerebral cortex development (P-v

47 = 1.26E-3), and cerebral cortex development (P-value = 1.31E-2).

48 covery and replication analyses (interaction p-value = 1.7 x 10(-8)).

49 ressive symptoms (N=2393, betaT-allele=2.33, P-value=1 x 10(-4)) and explained 2.9% of the estimated

50 ), gamma-aminobutyric acid (GABA) transport (P-value=1.36 x 10(-11)) and neuron cell-cell adhesion (P

51 36 x 10(-11)) and neuron cell-cell adhesion (P-value=1.48 x 10(-13)).

52 with circulating FXI levels: KNG1 (rs710446, P-value = 2.07 x 10-302), F11 (rs4253417, P-value = 2.86

53 his variant with obesity (odds ratio = 2.34, p-value = 2.59 x 10(-3)), highlighting the challenges of

54 -value = 3.6 x 10(-7)), more skin wrinkling (P-value = 2.6 x 10(-16)), but not with more pigmented sp

55 6, P-value = 2.07 x 10-302), F11 (rs4253417, P-value = 2.86 x 10-193), and a novel association in GCK

56 ipants (odds ratio, 0.69; 95% CI= 0.55-0.93; P value: 2.7 x 10(-3)).

57 intron of TBCD) and rs8073471 (Deviance test P-value=2.77 x 10(-34)).

58 isk of Alzheimer's disease (odds ratio=2.01; P-value=2.8 x 10(-02)) compared with the non-carriers.

59 n average 18% (P value=6x10(-)(63)) and 24% (P value=2x10(-5)) lower for carriers of the variant, res

60 , and a novel association in GCKR (rs780094, P-value = 3.56 x10-09), here for the first time implicat

61 was associated with a higher perceived age (P-value = 3.6 x 10(-7)), more skin wrinkling (P-value =

62 Rotterdam study (N=1604, betaT-allele=3.60, P-value=3 x 10(-2)).

63 an increased burden of white matter lesions (P-value=3.3 x 10(-02)) and a higher risk of Alzheimer's

64 h military cohort (N=93; B=-0.054, t=-3.706, p-value=3.66 x 10(-4)).

65 1) and the response to IVIG (Fisher's exact P value 4.518x10(-)(03) and 8.224x10(-)(10), respectivel

66 age than among those > 65 years (interaction p-value = 4.0 x 10(-5)).

67 icantly associated with depressive symptoms (P-value=5.2 x 10(-08), beta=7.2).

68 ciation with atopy (rs4916831, meta-analysis P value = 6.8 x 10(-9)).

69 Baseline and SDs of CK were on average 18% (P value=6x10(-)(63)) and 24% (P value=2x10(-5)) lower fo

70 612) confirmed the association of Asn396Ser (P-value=7.1 x 10(-03), beta=2.55) with depressive sympto

71 ale alcohol consumption was 0.90 (s.e.=0.09, P-value=7.16 x 10(-23)).

72 by CADM2 is involved in glutamate signaling (P-value=7.22 x 10(-15)), gamma-aminobutyric acid (GABA)

73 on in people who smoked tobacco (interaction P value=8.7x10(-5)).

74 ion (parameter estimate (SE) = -1.14 (0.20); p-value = 9.1 x 10(-9)).

75 p-Values above the significance threshold but less than

76 o reduce noise, the "adaptive combination of P-values" (ADA) method removes variants with larger P-va

77 ratio, 1.17 per 10% increases of CSP ratios; P value adjusted for multiple testing = .03).

78 ng black compared with 11% of CRVO patients (P value adjusted for multiple testing = 0.0001).

79 combined =1012) obtaining highly significant P-values also for GLRB single-nucleotide variants rs1703

80 We used Monte Carlo simulation to derive p values and 95% CIs for the difference in mortality ove

81 o implement the estimation of GGM and obtain p-value and confidence interval for each edge in the gra

82 isease progression stages are analyzed using p-value and their associated pathways.

83 the TDT test statistic, P-values, projected P-values and exponential mechanisms based on the TDT tes

84 ription, TF mRNA expression levels, TF motif P-values, and enrichment of H3K4me1 and H3K27ac.

85 affected than to the unaffected of the CDS (P value approximately 0.00001).

86 We developed an efficient and accurate p -value approximation procedure using analytical decomp

87 me measures at week 52 were exploratory, and P values are considered nominal.

88 ons of their psychotic experiences (p<0.008; p values are Sidak adjusted to account for multiple test

89 Furthermore, the derived P-values are known to be conservative when sample size i

90 Rather than reporting isolated P values, articles should include effect sizes and uncer

91 ixed types of traits, and to Z-statistics or P-values as summary statistics obtained from either a si

92 two-sided significance level of 0.001 and a p value at or below this limit for both primary endpoint

93 replication analyses were performed using a p-value-based meta-analysis.

94 wer educational and occupational attainment (p values between 10(-7) and 10(-18)).

95 in ATG7 (encoding Autophagy Related 7), with P values between 2.52 x 10(-6) and 3.59 x 10(-6), were i

96 EOAD (P = 2.05 x 10-6; Bonferroni-corrected P value [BP] = 1.3 x 10-3) and LOAD (P = 6.22 x 10-6; BP

97 actice, it is usually necessary to calculate p-value by a permutation procedure.

98 SMITE combines p-values by accounting for the correlation between non-i

99 n the permutation procedure is necessary for p-value calculation.

100 P values can be reframed to lessen distortions by presen

101 of this distribution is provided from which P-values can be easily computed.

102 cts with scores <2 (1.7% vs. 2.3%; p = 0.42; p value comparing risk differences = 0.03).

103 ve results are presented as mean+/-2 SE, and P values comparing the area under the curve of the gener

104 For each index we defined a critical P value CritIndex, such that 5% of test-retest series sh

105 reased variation explained at more stringent P value cut points in the CAMP EA cohort (P<0.05).

106 lative to the median angle (-8.13 degrees ), PD values decreased in lower nasal (ADSP: -0.11 dB) and

107 an median distance (14.32 degrees ), average PD values decreased in the upper central (average differ

108 emRICH sets have a self-contained size where p-values do not rely on the size of a background databas

109 a 3.9 day increase in ventilator-free days, p value equals to 0.01.

110 Moreover, the permutation-based P -value estimation methods have been replaced by exact

111 The interaction p-value exceeded genome-wide significance in combined di

112 veloped a novel method to compute gene-level P-values (fastCGP), and proposed a parallel dense-module

113 ozygotes (Cox proportional hazards analysis, p value for combined meta-analysis [pcom] = 1.9 x 10(-5)

114 performance (AUC, 0.930 vs. 0.891; 2-tailed P value for difference, 0.31).

115 and bleeding), whether viewed individually (p value for each >0.40) or collectively (36.9% in placeb

116 ssion analysis (18,863 probes) resulted in a p value for each gene in each study.

117 sk allele and NKTCL susceptibility (OR 2.38, p value for haplotype 2.32 x 10(-14)).

118 R 0.85, 95% CI 0.75-0.96 vs 1.06, 0.95-1.17; p value for interaction 0.007).

119 low birthweight (RR 0.81, 95% CI 0.74-0.89; p value for interaction 0.049), small-for-gestational-ag

120 onfidence interval, .004 to .059]; P = .04) (P value for interaction = .01) among helminth-infected s

121 s most marked among those with older donors (P value for interaction = 0.01).

122 al ischemic time, donor age, and graft loss (P value for interaction = 0.03).

123 c strain functional decay than those of men (P value for interaction, <0.05), with men showing higher

124 her volume of white matter hyperintensities (P value for interaction=0.019).

125 .36 for every increase in severity category; P value for linear trend = .003).

126 feriority primary endpoint was not achieved (p value for noninferiority = 0.843).

127 ependently associated with ECA in both PLTR (P value for trend < 0.0001) and BLTR (P value for trend

128 vs </=8.9 MET-hours/week; 95% CI, 0.59-0.93; P value for trend = .003).

129 PLTR (P value for trend < 0.0001) and BLTR (P value for trend = 0.03).

130 ting the dataset further increased accuracy (P values for AlexNet and GoogLeNet were .03 and .02, res

131 y tended to be stronger among never-smokers (P values for interaction 0.06 and 0.01, respectively).

132 p values for interaction for all other subgroup analyses

133 r between participants with and without CKD (P values for interactions >/=0.30).

134 We used the Stouffer-Liptak test to combine P values for metaanalysis.

135 act permutation tests were used to calculate P values for the log-rank tests.Twenty patients received

136 showed a decrease in the initiation of VKA (p-value for decreasing trend, p < 0001) and an increase

137 -0.11-0.21) per SD increase in maternal BMI (p-value for difference between the two results = 0.05).

138 tional analysis was 1.43 (95% CI, 1.19-1.67; P-value for heterogeneity =0.76).

139 the initiation of rivaroxaban and apixaban (p-value for increasing trend, p < 0001).

140 low traffic-related air pollution exposure (P-value for interaction = 0.029).

141 this relationship appeared to differ by age (p-value for interaction = 0.03).

142 istory of allergy, eczema, or asthma (lowest P-value for interaction=.13).

143 calculation an effect size and corresponding p-value for the whole gene rather than for single varian

144 among those recruited in waves 26 and above (p-value for trend < 0.001).

145 ed with an overall increased risk of eczema (P-value for trend <.05).

146 for the third compared to the first tertile, P-value for trend = 0.031).

147 eloped an R package called pulver to compute p-values for the interaction term in a very large number

148 an intercept of 0.007 (standard error, 0.12; P value [for difference from 0] =0.95).

149 with a slope of 0.97 (standard error, 0.04; P value [for difference from 1] =0.53) and an intercept

150 Using GWAS summary statistics (P-values) for SNPs along with reference genes for a dise

151 Because the 1-tailed P value from the Fisher exact test was <.001, which cros

152 independently associated with mortality (all p values >0.06).

153 ficantly affect neuropsychological measures (p values >0.5); however, a lower verbal learning score c

154 associated with higher 25-hydroxyvitamin D (P-values > 0.05).

155 not associated with any skin aging feature (P-values > 0.05).

156 solids, total anthocyanin and DPPH activity (p-value>0.05).

157 The use and misuse of P values has generated extensive debates.

158 It also reports a P -value in favour of rejecting a constant-expression mo

159 lucocorticoid dose of >0.9 with FDR adjusted P values in the range 3.3 E-04 -1.9 E-10.

160 leotide polymorphisms (SNPs) with the lowest P-values in a genome-wide association meta-analysis (GWA

161 gher daily doses (>1.5 vs <0.75 PPI pills/d; P value interaction = .004) and decreased after medicati

162 leading, as in inferences based on whether a P value is "statistically significant"; 2) nullism, the

163 Its P-value is typically assessed via its (unconditional) as

164 n 2013; (absolute increase of $233 million), p value less than 0.0001.

165 A P value less than 0.05 was considered to indicate a sign

166 14 of these genes had p values less than 0.05 for associations with progressio

167 1.6 [95% confidence interval [CI], 1.4,1.7], P value < .0001) and IFN-gamma ELISPOT (estimated GMFR =

168 POT (estimated GMFR = 2.0 [95% CI, 1.6,2.6], P value < .0001); both results met the prespecified succ

169 ikely to have meropenem MICs </=1 microg/mL (P value < .001).

170 aluated by analysis of variance (significant P value < .05), hierarchical cluster algorithm, and path

171 und SNPs in 10 genes/loci that had a summary P value < 0.05.

172 hat test a reduction of therapy, a one-sided P value </= .10 was used to indicate statistical signifi

173 different among survived and those who died (P value </=0.05).

174 lithiasis between the patients and controls (p value <0.001 for both comparisons).

175 A 2-tailed P value <0.01 was considered to denote statistical signi

176 entially expressed miRNAs (fold change >1.5; P value <0.01) were identified, including 13 miRNAs betw

177 .63, 0.42, 0.56, and 0.80, respectively; all P values < .0001) and coronal oblique acquisitions (mean

178 .09, 0.65, 0.93, and 1.12, respectively; all P values < .0001).

179 5,5)SumEntrp (in patients with large MI: all P values < .001; in patients with small MI: Teta1 and Pe

180 ioning, and acute graft-versus-host disease (P values < .01).

181 had lower sleep efficiency (72.3 vs. 82.2%) (P values < 0.001).

182 tality (HR: 2.26; 95% CI: 1.86 to 2.74), all p values < 0.001, compared with patients without AF.

183 ciated with decreased placental mtDNAcn (all P values < 0.05).

184 s using milestone ratings than the RAES (all P values <.001).

185 Variables with P values <.25 in the univariable analyses were evaluated

186 P values </= .05 were considered to indicate a statistic

187 or-profit institutions (8.8% vs. 19.9%) (all P values <0.001).

188 ful and easy to understand than the NIP (all P values <0.001).At the relatively low level of use obse

189 Two-sided P values <0.05 were considered significant.We observed a

190 C), and some sectors of outer nuclear layer (P- values </=0.05) was found with no significant differe

191 f workup (NWU, 9.2%; LWU, 33.3%, CWU, 67.1%; p-value < 0.0001).

192 with more than 5 radon Spearman's Rho 0.286 (p-value < 0.001) and Spearman's Rho 0.509 (p-value < 0.0

193 (p-value < 0.001) and Spearman's Rho 0.509 (p-value < 0.001) for males and females, respectively.

194 ubjects (betafreq.users dinner*time = 0.007, p-value < 0.001).

195 ed weight loss in a significant way (80.39%, p-value < 0.001).

196 mbined fold change >/=2 and Student's t-test p-value < 0.05 to denote significance; associations with

197 tudent's t-test, two-tailed unequal variance p-value < 0.05) between spectra representing healthy and

198 176 proteins were altered at least 1.5-fold (p-value < 0.05) in abundance during hypochlorite stress.

199 differentially expressed peptides (adjusted p-value < 0.05) were analysed with the Proteasix tool pr

200 ated CVD rates in Japan by a factor of 0.42 (p-value < 0.05).

201 crease in the rate of overwork-related CVDs (p-value < 0.05).

202 At FDR adjusted p-value < 0.05, 29 genes were differentially expressed i

203 Those with a screening interaction p-value < 10(-5) were evaluated in the follow-up analysi

204 The HLA-B27 antigen was more prevalent (p-value < 2.2 x 10(-8)) in the CWU HEDS patients (23.9%)

205 the differences were extremely significant (p-value < 2.2e-16).

206 on variant associations with peptide levels (P-value < 4.2 x 10-10), including 16 novel gene-peptide

207 ignificantly associated with peptide levels (P-value < 4.2 x 10-10).

208 We identified 10 novel loci with p-value < 5 x 10(-8) previously missed by HapMap-based G

209 1 and UST) showed statistically significant (p-value </= 0.05) evidence of association, either overal

210 A total of 82 variants with p-value </=1 x 10(-5) were followed up in 373 African Am

211 fitted the experimental data (R(2): 0.9736; p-value <0.0001).

212 cy in animal models than expected by chance (P-value <0.006).

213 fect of enzymatic units and incubation time (p-value <0.015), while CER was found to be affected by t

214 by the quadratric effect of both variables (p-value <0.022-0.052).

215 P-value <0.05 was considered statistically significant.

216 of 76 proteins (a fold change >1.4, or <0.6, p-value <0.05) and several of these matched the stress p

217 A significant increase (p-value <0.05) in acrylamide content was observed for mo

218 d reached Bonferroni corrected significance (p-value <5 x 10(-7)).

219 iglycerides (p = 0.01), insulin and HOMA-IR (p-values < 0.05).

220 ase 4D, cAMP-specif (PDE4D) and 26 SNPs with P-values < 1*10(-5) were found.

221 For X-rays (0.3 kGy), melanin protected CA (p-values < 10(-4) ) and probably CN.

222 dose (1.5 kGy) deuterons for both CN and CA (p-values < 10(-4) ).

223 We detected significant associations (P-values <5 x 10(-5), Bonferroni-corrected P<0.05) for n

224 behaviors in boys, but not in girls (BPAxsex p&-values</=0.08).

225 types of activities (p-value<0.001), roles (p-value<0.001) and funding sources (p-value<0.001) of or

226 , roles (p-value<0.001) and funding sources (p-value<0.001) of organisations concerning diabetes self

227 ries in relation to the types of activities (p-value<0.001), roles (p-value<0.001) and funding source

228 associated with use of cologne/perfume (83%, p-value<0.01) and deodorant (74%, p-value<0.01).

229 fume (83%, p-value<0.01) and deodorant (74%, p-value<0.01).

230 75, 95% confidence interval [CI]: 1.08-2.83, P-value<0.05).

231 -P scores was modified by child sex (BPAxsex p-values</=0.03).

232 detect LGT in Wolbachia-depleted B. malayi (p-value: <2e-16).

233 er of compounds detected (linear regression; p-values: < 0.001-0.012), providing a statistical infere

234 4 for alirocumab versus control (interaction P-values non-significant).

235 All relevant data, including outcome, P value, number of patients in each group, number of eve

236 g L(-1) changed transcription of 2692 genes (p value of <0.001, fold change of >/=2) after 7 days of

237 A P value of <0.05 was accepted as the level of significan

238 nalyses were declared to be significant at a P value of <1.0x10(-3) (Bonferroni correction for 50 tes

239 d a positivity rate of 1.0% (CI, 0.2 to 1.7; P value of 0.0002 versus QFT-Plus and 0.07 versus QFT).

240 s 1.31; 95% CI 1.25-1.38 in men; interaction P value of 0.001).

241 of 0.05 or less, and secondary outcomes at a P value of 0.01 or less.

242 NYVAC-KC priming significantly more (up to a P value of 0.01) than in a group without poly-ICLC.

243 0.92; 95% CI, 0.88-0.97 in men; interaction P value of 0.023).

244 P value of 0.05 or less was considered as statistically

245 Primary outcomes were assessed at a P value of 0.05 or less, and secondary outcomes at a P v

246 erence between aluminum and iron electrodes (P value of 0.0526-0.9487).

247 line DBP, 82+/-9 mm Hg), with an interaction P value of 0.78.

248 0 of our previous and present study showed a p value of 9.2 x 10(-19).

249 ney U and Wilcoxon signed-rank tests, with a P value of less than .05 considered indicative of a sign

250 l studies: relative risk = 0.73 (0.67-0.80); p value of less than 0.0001 but not with randomized stud

251 h: relative risk = 0.77 (95% CI, 0.71-0.83); p value of less than 0.0001.

252 -protective ventilation from 11.1% to 61.5%, p value of less than 0.01.

253 g >70% soluble phosphorus and aluminum <40% (P values of 0.0035-0.0143).

254 erquartile ranges of 2.9-5.7 and 3.4-6.3 and P values of 0.004 and 0.008) than for (68)Ga-DOTATOC (1.

255 ge of emphysema in RUL, RLL, and both lungs (P values of 0.024, 0.016, and 0.036, respectively).

256 Variables with p values of less than 0.1 were considered for logistic r

257 nosorbent assay (ELISA) conventional method (p-value of < 0.05) showed that this immunosensor can be

258 ffecting ND in this sample with an empirical p-value of 0.0015.

259 ed at the genome-wide level of significance, P-values of potential relevance were observed for the po

260 Additionally, we compared PD values of groups with longer and shorter distances th

261 Pattern deviation (PD) values of 11,449 reliable visual fields (VFs) that a

262 od to estimate the statistical significance (P values) of chromatin interactions from Hi-C experiment

263 by multivariate regression included smaller P value (P < 0.001), larger sample size (P = 0.001), lar

264 serum retinol below the Bonferroni-corrected P-value (p < 5.3 x 10(-5)).

265 xceeding the study-wide Bonferroni-corrected P-value (PBonf < 0.0023, Pcombined = 1.1 x 10(-9), 1.4 x

266 , while correlation with hydrophobicity (log P values), pKa, and the inverse calculated surface tensi

267 mechanisms based on the TDT test statistic, P-values, projected P-values and exponential mechanisms

268 for serotypes 6A, 6B, 18C and 23F (adjusted p value range <0.0001 to 0.017).

269 19F (14.76 mug/mL vs 11.12 mug/mL; adjusted p value range <0.001 to 0.047).

270 andidate biomarkers increased significantly (P value range, <.0001 to .04) relative to sham-treated c

271 ommon variants (>/=5%) associated with AF at P values ranging from <1x10(-3) to <1x10(-8) in a prior

272 patients with MDS and patients with MDS/AML (P values ranging from .003 to .035).

273 iolence (AORs ranged from 0.29 to 0.70, with p-values ranging from <0.001 to 0.07).

274 rmative (AORs ranged from 0.49 to 0.65, with p-values ranging from <0.001 to 0.14).

275 howed significant associations with ND, with p-values ranging from 6.86 x 10(-14) for rs13280604 to 6

276 P values reported for the neuroimaging results are all f

277 The analysis of identification p-values suggests that the current technology is already

278 A Bayesian method identified the largest p-value threshold (q = .025) associated with twice the n

279 However, after relaxing the p-value threshold to include variants from more than one

280 At various suggestive p-value thresholds, the smoking adjusted lung function t

281 WAS, defined as ratio of the log-transformed p-value to the sample size, in larger samples was larger

282 es calculated for the comparator assays (all P values were >0.1).

283 However, the interaction P values were 0.32 and 0.34, respectively.

284 ts performed after 3 days and the associated P values were 54.1% for O&P examinations (P < 0.0001), 2

285 P values were adjusted based on the Hochberg step-up met

286 P values were adjusted for age, sex, carotid artery site

287 were obtained by using bootstrap resampling; P values were calculated by using a t test.

288 P values were corrected for false discovery rate.

289 All P values were corrected for multiple hypothesis testing

290 P values were corrected for multiple testing using false

291 All p values were one-sided and multiplicity-adjusted.

292 For this analysis, p values were significant at the false discovery rate co

293 odels were adjusted for age and smoking, and p-values were adjusted for false discovery.

294 P-values were adjusted for multiple comparisons, and per

295 sis was performed using Phyloseq and DESeq2; P-values were adjusted for multiple comparisons.

296 Nominally, significant P-values were obtained for 78 of the 617 investigated mi

297 of Fisher's method) for combining dependent P-values which is appropriate for the large and correlat

298 we developed an efficient method to estimate P -values while controlling the mutation rates of indivi

299 We also combined the resulting P values with Fisher's method to estimate the associatio

300 the transformed differential expression test P-values (z-scores), it is generally applicable to the e